Natural Alternatives International (NASDAQ:NAII) Now Covered by StockNews.com

Posted by ABMN Staff on Dec 4th, 2024

Research analysts at StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII – Get Free Report) in a report issued on Wednesday. The firm set a “buy” rating on the stock.

Natural Alternatives International Stock Down 2.8 %

NASDAQ:NAII opened at $4.50 on Wednesday. The company’s fifty day moving average price is $4.67 and its 200-day moving average price is $5.54. The firm has a market capitalization of $27.90 million, a P/E ratio of -3.13 and a beta of 0.60. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.56 and a quick ratio of 1.50. Natural Alternatives International has a 1-year low of $4.11 and a 1-year high of $7.37.

Natural Alternatives International (NASDAQ:NAII – Get Free Report) last posted its earnings results on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. The firm had revenue of $29.49 million during the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC grew its position in Natural Alternatives International, Inc. (NASDAQ:NAII – Free Report) by 6.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the quarter. Geode Capital Management LLC owned about 0.73% of Natural Alternatives International worth $258,000 as of its most recent SEC filing. 32.40% of the stock is currently owned by hedge funds and other institutional investors.

Natural Alternatives International Company Profile

(Get Free Report)

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.